Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

Merck says drug for CMV in transplant patients hits targets

Letermovir on course for fast-track 2017 filing and head start in prospective $350m market

- PMLiVE

Time for a new language for asthma?

Many patients lack an understanding of what ‘control’ means

- PMLiVE

Two-thirds of HCPs access drug data online every week

EPG survey also finds similar numbers search out treatment guidelines

- PMLiVE

AXON expands with new Switzerland branch

Establishes new operation to support head offices of Swiss clients

Roche Basel Switzerland

Lung cancer OK for Tecentriq sets up showdown with Merck and BMS

Broad label will aid Roche’s PD-L1 inhibitor in head-to-head NSCLC market-share battle

- PMLiVE

J&J’s Caruso bullish on Remicade defence plans

Believes top-selling arthritis treatment will weather introduction of biosimilars in US market

The one multichannel question you must ask

There is a question every marketer should ask when designing a multichannel communications strategy

Anthill Agency

Celgene plans real-world study using Apple’s ResearchKit

Will develop an iPhone app to assess burden of chronic anaemia

Celgene building

Celgene plans real-world study using Apple’s ResearchKit

Will develop an iPhone app to assess burden of chronic anaemia

- PMLiVE

Galenica Group strengthens management team

Appoints Stefan Schulze, Felix Burkhard and Jörg Kneubühler

- PMLiVE

Mastering the rare disease challenge

Identifying expertise and customising communication in orphan drug marketing

- PMLiVE

Shire wins EU licence for pancreatic cancer drug Onivyde

Combination treatment is the first approved for this patient population

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links